Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma

por Hongfu Cai, Baohua Xu, Na Li, Bin Zheng, Zhiwei Zheng, Maobai Liu
Publicado 2021

Clinical evolution of ST11 carbapenem resistant and hypervirulent Klebsiella pneumoniae

por Miaomiao Xie, Xuemei Yang, Qi Xu, Lianwei Ye, Kaichao Chen, Zhiwei Zheng, Ning Dong, Qiaoling Sun, Lingbin Shu, Danxia Gu, Edward Wai-Chi Chan, Rong Zhang, Sheng Chen
Publicado 2021